Emily Bodnar
Stock Analyst at HC Wainwright & Co.
(0.86)
# 3,895
Out of 4,996 analysts
323
Total ratings
25%
Success rate
-26.09%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Emily Bodnar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AGEN Agenus | Reiterates: Buy | $23 | $3.95 | +482.28% | 20 | Sep 10, 2025 | |
| AGIO Agios Pharmaceuticals | Reiterates: Buy | $56 | $38.93 | +43.85% | 2 | Sep 4, 2025 | |
| BCTX BriaCell Therapeutics | Maintains: Buy | $32 → $40 | $11.04 | +262.32% | 15 | Aug 27, 2025 | |
| INKT MiNK Therapeutics | Upgrades: Buy | $35 | $13.96 | +150.72% | 14 | Aug 15, 2025 | |
| VTVT vTv Therapeutics | Reiterates: Buy | $36 | $22.40 | +60.75% | 2 | Aug 13, 2025 | |
| FEMY Femasys | Maintains: Buy | $12 → $8 | $0.36 | +2,123.46% | 25 | Aug 11, 2025 | |
| CNTX Context Therapeutics | Maintains: Buy | $5 → $4 | $0.91 | +339.56% | 12 | Aug 7, 2025 | |
| SABS SAB Biotherapeutics | Maintains: Buy | $10 → $9 | $2.01 | +347.76% | 2 | Jul 22, 2025 | |
| RAPT RAPT Therapeutics | Maintains: Buy | $6 → $27 | $26.38 | +2.35% | 2 | Jul 10, 2025 | |
| JSPR Jasper Therapeutics | Maintains: Buy | $40 → $20 | $2.47 | +709.72% | 10 | Jul 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $36 | $5.70 | +531.58% | 9 | Jul 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $115 | $79.69 | +44.31% | 13 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $12 | $2.96 | +305.41% | 1 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $22 → $38 | $23.58 | +61.15% | 10 | Jun 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $9.51 | +215.46% | 20 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $3.34 | +229.34% | 11 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $560 → $280 | $10.17 | +2,653.20% | 17 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $1.58 | +406.33% | 6 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $1.58 | +659.49% | 13 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $4.18 | +617.70% | 7 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $1.66 | +1,044.58% | 12 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $2.04 | +782.35% | 15 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $183 | $5.18 | +3,425.29% | 12 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $0.86 | +715.38% | 14 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $1.29 | - | 5 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $24 | $12.84 | +86.92% | 5 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $1.66 | +984.34% | 1 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $2.98 | - | 15 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $38 | $12.89 | +194.80% | 18 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $33 | $0.60 | +5,404.59% | 14 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $4.46 | - | 1 | Apr 25, 2024 |
Agenus
Sep 10, 2025
Reiterates: Buy
Price Target: $23
Current: $3.95
Upside: +482.28%
Agios Pharmaceuticals
Sep 4, 2025
Reiterates: Buy
Price Target: $56
Current: $38.93
Upside: +43.85%
BriaCell Therapeutics
Aug 27, 2025
Maintains: Buy
Price Target: $32 → $40
Current: $11.04
Upside: +262.32%
MiNK Therapeutics
Aug 15, 2025
Upgrades: Buy
Price Target: $35
Current: $13.96
Upside: +150.72%
vTv Therapeutics
Aug 13, 2025
Reiterates: Buy
Price Target: $36
Current: $22.40
Upside: +60.75%
Femasys
Aug 11, 2025
Maintains: Buy
Price Target: $12 → $8
Current: $0.36
Upside: +2,123.46%
Context Therapeutics
Aug 7, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $0.91
Upside: +339.56%
SAB Biotherapeutics
Jul 22, 2025
Maintains: Buy
Price Target: $10 → $9
Current: $2.01
Upside: +347.76%
RAPT Therapeutics
Jul 10, 2025
Maintains: Buy
Price Target: $6 → $27
Current: $26.38
Upside: +2.35%
Jasper Therapeutics
Jul 7, 2025
Maintains: Buy
Price Target: $40 → $20
Current: $2.47
Upside: +709.72%
Jul 1, 2025
Reiterates: Buy
Price Target: $36
Current: $5.70
Upside: +531.58%
Jun 16, 2025
Reiterates: Buy
Price Target: $115
Current: $79.69
Upside: +44.31%
Jun 11, 2025
Assumes: Buy
Price Target: $12
Current: $2.96
Upside: +305.41%
Jun 4, 2025
Upgrades: Buy
Price Target: $22 → $38
Current: $23.58
Upside: +61.15%
Apr 28, 2025
Reiterates: Buy
Price Target: $30
Current: $9.51
Upside: +215.46%
Apr 24, 2025
Reiterates: Buy
Price Target: $11
Current: $3.34
Upside: +229.34%
Apr 16, 2025
Maintains: Buy
Price Target: $560 → $280
Current: $10.17
Upside: +2,653.20%
Apr 1, 2025
Reiterates: Buy
Price Target: $8
Current: $1.58
Upside: +406.33%
Apr 1, 2025
Reiterates: Buy
Price Target: $12
Current: $1.58
Upside: +659.49%
Mar 31, 2025
Reiterates: Buy
Price Target: $30
Current: $4.18
Upside: +617.70%
Mar 28, 2025
Reiterates: Buy
Price Target: $19
Current: $1.66
Upside: +1,044.58%
Mar 27, 2025
Reiterates: Buy
Price Target: $18
Current: $2.04
Upside: +782.35%
Mar 26, 2025
Reiterates: Buy
Price Target: $183
Current: $5.18
Upside: +3,425.29%
Mar 26, 2025
Reiterates: Buy
Price Target: $7
Current: $0.86
Upside: +715.38%
Mar 12, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.29
Upside: -
Feb 26, 2025
Upgrades: Buy
Price Target: $24
Current: $12.84
Upside: +86.92%
Feb 3, 2025
Reiterates: Buy
Price Target: $18
Current: $1.66
Upside: +984.34%
Jan 14, 2025
Reiterates: Neutral
Price Target: n/a
Current: $2.98
Upside: -
Jan 14, 2025
Reiterates: Buy
Price Target: $38
Current: $12.89
Upside: +194.80%
Nov 15, 2024
Reiterates: Buy
Price Target: $33
Current: $0.60
Upside: +5,404.59%
Apr 25, 2024
Reiterates: Neutral
Price Target: n/a
Current: $4.46
Upside: -